Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bhavesh Bandekar"'
Publikováno v:
Perspectives in Clinical Research, Vol 13, Iss 3, Pp 145-150 (2022)
Context: A failure to obtain continued Institutional Ethics Committee (IEC) approval for the study before the expiry date assigned by the IEC is considered as “lapse of the IEC approval” to continue the study at the site by the Investigator. Cons
Externí odkaz:
https://doaj.org/article/62327a74e3774d3a8c03824f2da4c31e
Autor:
Vijay M Patil, Amit Joshi, Vanita Noronha, Vikas Talreja, Vijai Simha, Sachin Dhumal, Bhavesh Bandekar, Arun Chandrasekharan, Kumar Prabhash
Publikováno v:
South Asian Journal of Cancer, Vol 8, Iss 3, Pp 173-177 (2019)
Introduction: Nasopharyngeal carcinoma is a rare malignancy. We conducted an audit of systemic therapies received in palliative setting in carcinoma nasopharynx and studied their outcomes. Methods: Patients who underwent first-line palliative systemi
Externí odkaz:
https://doaj.org/article/66fca4b1929c4799ac0af3172c82e053
Autor:
Kasturi Awatagiri, Durga Gadgil, Sadhana Kannan, Pallavi Rane, Bhavesh Bandekar, Nilam Sawant, Prafulla Parikh, Vedang Murthy
Publikováno v:
Perspectives in Clinical Research, Vol 10, Iss 1, Pp 20-25 (2019)
Context: Adherence to good clinical practice (GCP) guidelines by the researcher provides public confidence that the rights, safety and well-being of human participants involved in research are protected. It has been observed that researchers require
Externí odkaz:
https://doaj.org/article/0d28136a01a74781aba0a9b0dfd29ea2
Publikováno v:
Perspectives in clinical research. 13(3)
A failure to obtain continued Institutional Ethics Committee (IEC) approval for the study before the expiry date assigned by the IEC is considered as "lapse of the IEC approval" to continue the study at the site by the Investigator. Considering this,
Autor:
Vijay Patil, Bhavesh Bandekar, Sabita Jiwnani, Amit Joshi, Nilendu Purandare, Dipti Nakti, Vanita Noronha, Sarbani Ghosh-Laskar, Kumar Prabhash
Publikováno v:
Journal of Gastrointestinal Cancer. 47:294-304
Esophageal cancer with tracheobronchial involvement (TBI) has a poor prognosis. Radical therapy carries the risk of inducing tracheoesophageal fistula (TEF) and treatment-related mortality. Induction chemotherapy followed by reassessment for radical
Autor:
Pallavi Rane, Prafulla Parikh, Vedang Murthy, Sadhana Kannan, Durga Gadgil, Nilam Sawant, Kasturi Awatagiri, Bhavesh Bandekar
Publikováno v:
Perspectives in Clinical Research, Vol 10, Iss 1, Pp 20-25 (2019)
Perspectives in Clinical Research
Perspectives in Clinical Research
Context: Adherence to good clinical practice (GCP) guidelines by the researcher provides public confidence that the rights, safety and well-being of human participants involved in research are protected. It has been observed that researchers require